Hurum

Hurum is a KOSDAQ-listed food and beverage company that manufactures and distributes health supplements based on red ginseng, probiotics, and fermentation technology.

Its key brands include the probiotic line Trueluck, the hemp seed oil product Venergy, the yogurt-related line Yogus, and cafe-use raw material supplies, and through the acquisition of e-commerce-focused health supplement firm Nature Garden it also secured the red ginseng brand Jungwonsam.

Sales channels are diversified across home shopping, online platforms, large-format retailers, and military welfare procurement, and the company has recently expanded into general food and lifestyle categories by launching the Italian wellness brand Misura at Costco.

Its subsidiary structure extends beyond a simple food company, including medical device (filler) maker Y.U, e-commerce health supplement firm Nature Garden, and agricultural corporation Hurum Farm.

Among these, Y.U markets bead-form fillers designed for extended in-body persistence and is expanding sales in emerging markets across Asia and Eastern Europe.

The domestic health supplement market is considered structurally growing on the back of an aging population, rising health awareness, and policy support, though industry-wide performance outside seasonal demand peaks such as holidays and Family Month is viewed as sluggish.

On the overseas front, the company established a joint venture in China in August 2025 (Yiyangjian Hurum Weihai) to pursue local market entry leveraging its yogurt manufacturing technology.

Overall, Hurum can be summarized as a multi-brand, multi-subsidiary company simultaneously pursuing domestic channel diversification in health supplements and overseas expansion in fillers and yogurt technology.

Hurum's consolidated revenue rose for four consecutive years, from KRW66.9bn in 2022 to KRW88.4bn in 2023, KRW98.2bn in 2024, and KRW99.0bn in 2025, maintaining a top-line growth trajectory.

Profitability, however, has been uneven: the company posted an operating loss of KRW1.70bn (margin -2.5%) in 2022, improved to an operating profit of KRW3.76bn (margin 4.2%) in 2023, then slowed again to KRW1.05bn (margin 1.1%) in 2024.

Operating profit recovered modestly to KRW1.87bn (margin 1.9%) in 2025 but remained below the 2023 level. Net income attributable to owners moved from -KRW1.32bn in 2022 to KRW3.27bn in 2023, KRW1.76bn in 2024, and KRW1.16bn in 2025, staying in profit but on a declining trend.

On a quarterly basis, 2Q25 showed solid results with revenue of KRW23.93bn, operating profit of KRW0.53bn, and owner net income of KRW1.65bn, but 3Q25 revenue rose to KRW26.34bn while operating profit shrank to just KRW0.007bn and net income swung to a loss of -KRW0.54bn. 4Q25 returned to profit with revenue of KRW23.54bn, operating profit of KRW1.04bn, and net income of KRW0.11bn, but 2026 brought consecutive declines, with 1Q26 revenue of KRW23.05bn and an operating loss of -KRW0.22bn (net income -KRW0.12bn), followed by 2Q26 revenue of KRW21.96bn and a widened operating loss of -KRW0.81bn (net income KRW0.016bn).

Over the trailing four quarters (3Q25-2Q26), combined owner net income totaled roughly -KRW0.53bn, meaning the most recent one-year window has slipped into a net loss even though full-year 2025 was profitable.

On the balance sheet side, the debt ratio rose every year from 63.6% in 2022 to 84.0% in 2023, 96.6% in 2024, and 113.8% in 2025, indicating growing leverage alongside revenue expansion.

Korea's health supplement industry is considered structurally growing, supported by an aging population, rising health awareness, and policy backing, but industry-wide performance outside seasonal demand spikes such as holidays and Family Month is seen as declining.

Amid this environment, Hurum has been assessed as relatively holding up through channel diversification across home shopping, online, large-format retail, and military supply.

The filler market is growing on the back of rising procedure demand combined with falling procedure prices, with growth particularly expected in emerging markets such as Asia and Eastern Europe, positioning subsidiary Y.U to benefit from this trend.

However, the domestic filler and aesthetics market already includes large medical aesthetics companies such as Hugel with established global distribution and brand power, meaning the comparatively smaller Y.U must rely on emerging-market channel expansion and product differentiation, such as its bead-form filler, to carve out a niche.

In the health supplement segment, categories such as probiotics and red ginseng constitute a mature market with numerous competitors, where brand trust and channel control remain the key competitive variables.

Overall, Hurum's business spans two different cycles: a mature domestic health supplement market and a growing emerging-market filler business.

In April 2026, Hurum launched the Italian premium wellness snack brand Misura at Costco, expanding its distribution portfolio beyond health supplements into general food and lifestyle categories.

Its flagship Venergy hemp seed oil product surpassed cumulative home-shopping sales of KRW60bn and recorded roughly KRW18.7bn in sales during 2025 alone, confirming continued growth momentum.

Overseas, the company established a joint venture in China in August 2025 (Yiyangjian Hurum Weihai) to pursue local market entry based on its proprietary electricity-free yogurt-making technology, though this is still considered an early-stage revenue contributor.

Filler subsidiary Y.U has continued expanding sales on the strength of its bead-form product, making future production capacity additions and export market expansion key variables for its performance.

The R&D and integrated logistics center completed in Osong, Cheongju in June 2024 is cited as infrastructure that could influence future production efficiency and new product development speed.

Given that the company posted operating losses in both 1Q26 and 2Q26, a key point to watch is whether new channel contributions from Misura and the China joint venture in the latter half of 2026 can offset the slowdown in core business profitability.